EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers

Vikneswary Ravi Kumar, Nirmala Chandralega Kampan iD, Nor Haslinda Abd Aziz, Chew Kah Teik iD, Mohamad Nasir Shafiee, P Susthitha Menon iD

Cancers · 27.11.2023 · 15 (23) · 5607

DOI: 10.3390/cancers15235607 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.11.2023. Verfasst von Vikneswary Ravi Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dana Impak Perdana grant, National University of Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial Ovarian Cancer (EOC) is a leading cause of cancer-related deaths among women, mainly due to a lack of early detection and screening methods. Advanced immunoassay techniques, such as Luminex and proximity extension assay (PEA) technology, show promise in improving EOC detection by utilizing highly sensitive and specific multiplex panels to detect multiple combinations of biomarkers. However, these advanced immunoassay techniques have certain limitations, especially in validating the performance characteristics such as specificity, sensitivity, limit of detection (LOD), and dynamic range for each EOC biomarker within the panel. Implementing multiplexing in point-of-care (POC) biosensors can enhance EOC biomarker detection, with Surface Plasmon Resonance (SPR) being a versatile option among optical biosensors. There is no study on multiplex SPR biosensors specifically tailored for diagnosing EOC. Recent studies have shown promising results in the single detection of EOC biomarkers using SPR, with LOD for cancer antigen 125 (CA125) at 0.01 U/mL−1 and human epididymis protein 4 (HE4) at 1pM. This study proposes a potential roadmap for scientists and engineers in academia and industry to develop a cost effective yet highly efficient SPR biosensor platform for detecting EOC.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscancer antigen 125 (CA125)epithelial ovarian cancer (EOC)human epididymis protein 4 (HE4)immunoassaymultiplexsurface plasmon resonance (SPR)

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
  • Institute of Microengineering and Nanoelectronics (IMEN), Universiti Kebangsaan Malaysia (UKM), Bangi 43600, Malaysia.

ORCID-Profile: Nirmala Chandralega Kampan, Chew Kah Teik, P Susthitha Menon

Förderung

  • Dana Impak Perdana grant
  • National University of Malaysia

Zitieren

APA

Kumar, V. R., Kampan, N. C., Abd Aziz, N. H., Teik, C. K., Shafiee, M. N., & Menon, P. S. (2023). Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers. Cancers, 15(23), 5607. https://doi.org/10.3390/cancers15235607

Vancouver

Kumar VR, Kampan NC, Abd Aziz NH, Teik CK, Shafiee MN, Menon PS. Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers. Cancers. 2023;15(23):5607. doi:10.3390/cancers15235607

BibTeX
@article{Kumar2023,
  author = {Kumar, Vikneswary Ravi and Kampan, Nirmala Chandralega and Abd Aziz, Nor Haslinda and Teik, Chew Kah and Shafiee, Mohamad Nasir and Menon, P Susthitha},
  title = {Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {23},
  pages = {5607},
  doi = {10.3390/cancers15235607}
}
Kostenlos starten →